Model Levers
1. Competing Hypotheses Weight
Prevention Fatigue & Condom Use
40%
Reduced barrier contraception, PrEP behavioral displacement
Surveillance & Testing Bias
25%
Expanded asymptomatic PCR screening inflating case counts
Antimicrobial Resistance (AMR)
20%
Treatment failure extending infectious period of gonorrhoea
Dating App Concurrency & Mobility
15%
Cross-border European travel and rapid partner turnover
2. Public Health Countermeasures
Partner Contact Tracing Efficiency
60%
Proportion of partners notified and prophylactically evaluated
Asymptomatic Testing Cadence
1.5×
High-risk cohort screening frequency multiplier
Rapid Clinic Diagnosis & Rx
3 days
Average latency from symptom/notification to antimicrobial delivery
Epidemiological Projection (5-Year Horizon)
Baseline untreated surge vs. selected intervention policy for Western Europe
Simulated projection ready
Year 3 Baseline Cases
1,420,500
Without intervention
Year 3 With Intervention
980,200
Modeled policy impact
Infections Averted (Yr 3)
440,300
Cumulative reduction
Unmitigated Surge Curve
Intervention Policy Curve
Annual Surveillance Intervals
Dominant Transmission Driver:
Prevention fatigue & reduced condom use.
Behavioral changes following PrEP adoption and lowered fear of viral loads represent the strongest acceleration vector in this parameter set.